Indaptus Therapeutics
INDP
INDP
25 hedge funds and large institutions have $2.71M invested in Indaptus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
25
Holding in Top 10
–
Calls
$30K
Puts
$13K
Top Buyers
| 1 | +$116K | |
| 2 | +$55.1K | |
| 3 | +$7K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$4.4K |
Top Sellers
| 1 | -$302K | |
| 2 | -$105K | |
| 3 | -$81.9K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$48K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$35K |